Search Results - "González Porras, J.R"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2
  3. 3

    Chronic Venous Disease in Spain: Doctor–Patient Correlation by Lozano Sánchez, F.S, Carrasco Carrasco, E, Diaz Sánchez, S, González Porras, J.R, Escudero Rodríguez, J.R, Marinello Roura, J, Sánchez Nevarez, I

    “…Abstract Aim The present study aimed to demonstrate how the quality of life (QoL) perceived by patients with chronic venous disease (CVD) is correlated with…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Peripheral endothelial progenitor cells (CD133+ ) for therapeutic vasculogenesis in a patient with critical limb ischemia. One year follow-up by Cañizo, M.C, Lozano, F, González-Porras, J.R, Barros, M, López-Holgado, N, Briz, E, Sánchez-Guijo, F.M

    Published in Cytotherapy (Oxford, England) (2007)
    “…We present a patient with critical limb ischemia who was successfully treated with the injection of autologous peripheral blood (PB) CD133+ purified stem cells…”
    Get full text
    Journal Article
  7. 7

    The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome by Cordoba, I, Gonzalez-Porras, J.R, Such, E, Nomdedeu, B, Luño, E, de Paz, R, Carbonell, F, Vallespi, T, Ardanaz, M, Ramos, F, Marco, V, Bonanad, S, Sanchez-Barba, M, Costa, D, Bernal, T, Sanz, G.F, Cañizo, M.C

    Published in Leukemia research (01-03-2012)
    “…Abstract The severity of neutropenia in myelodysplastic syndrome (MDS) has not been completely studied. We analyzed the prognostic significance of severe…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Darbepoetin alfa for anemia in patients with low or intermediate-1 risk myelodysplastic syndromes and positive predictive factors of response by Villegas, A., Arrizabalaga, B., Fernández-Lago, C., Castro, M., Mayans, J.R., González-Porras, J.R., Duarte, R.F., Remacha, A.F., Luño, E., Gasquet, J.A.

    Published in Current medical research and opinion (01-05-2011)
    “…Abstract Background: Current guidelines support the use of erythropoiesis-stimulating agents for the treatment of anemia associated with low-risk…”
    Get full text
    Journal Article
  14. 14

    Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphism by Gonzalez-Porras, J.R, Martin-Herrero, F, Garcia-Sanz, R, Lopez, M.L, Balanzategui, A, Mateos, M.V, Pavon, P, Gonzalez, M, Alberca, I, San Miguel, J.F

    Published in Thrombosis research (01-01-2007)
    “…Abstract Despite the well-known pro-coagulant effect of hyperhomocysteinemia, data is limited regarding the result on recurrent coronary event (RCE) in young…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18